drugset / Trial / NCT02580149

The Effect of Ticagrelor or Clopidogrel on Endothelial Function During Acute and Chronic Treatment

NCT02580149

Phase 4 Completed 24 enrolled Michael Wolzt, Prof. MD
RandomizedParallel-groupSingle-blindTreatment

Summary

To investigate if treatment with ticagrelor can mitigate the transient loss of endothelium-dependent vasodilatation of the resistance vasculature following a short period of ischemia, compared with clopidogrel at standard clinical doses. The effect of ticagrelor or clopidogrel will be studied after a loading dose and after a two weeks period of regular intake on FBF in response to the vasodilators acetylcholine or nitroglycerin before and 10 min after a 20 min forearm ischemia, respectively.

Timeline

Start
2015-10
Primary completion
2016-03
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clopidogrel Small molecule 75 mg
Comparator Ticagrelor Small molecule 90 mg Oral

Indications